These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9610907)

  • 21. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.
    Yan W; Chen W; Huang L
    J Control Release; 2008 Aug; 130(1):22-8. PubMed ID: 18554742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
    Firouzmand H; Badiee A; Khamesipour A; Heravi Shargh V; Alavizadeh SH; Abbasi A; Jaafari MR
    Acta Trop; 2013 Dec; 128(3):528-35. PubMed ID: 23916506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
    Mansourian M; Badiee A; Jalali SA; Shariat S; Yazdani M; Amin M; Jaafari MR
    Immunol Lett; 2014 Nov; 162(1 Pt A):87-93. PubMed ID: 25086399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.
    Yan W; Huang L
    Int J Pharm; 2009 Feb; 368(1-2):56-62. PubMed ID: 18992312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
    Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA
    Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposome-mediated DNA vaccination: the effect of vesicle composition.
    Perrie Y; Frederik PM; Gregoriadis G
    Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
    Jiao X; Wang RY; Feng Z; Alter HJ; Shih JW
    Hepatology; 2003 Feb; 37(2):452-60. PubMed ID: 12540796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice.
    Li D; Hua S; Fan Y; Xu S; Duan X; Liu L; Che Y; Li S; Tan Y
    Immunol Lett; 2011 Mar; 135(1-2):124-8. PubMed ID: 21073899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen.
    Pervin S; Chakraborty M; Bhattacharya-Chatterjee M; Zeytin H; Foon KA; Chatterjee SK
    Cancer Res; 1997 Feb; 57(4):728-34. PubMed ID: 9044852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
    Baral RN; Saha A; Chatterjee S; Foon KA; Krieg A; Weiner GJ; Bhattacharya-Chatterjee M
    Cancer Immunol Immunother; 2003 May; 52(5):317-27. PubMed ID: 12700947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity.
    Mai Y; Guo J; Zhao Y; Ma S; Hou Y; Yang J
    Cell Immunol; 2020 Aug; 354():104143. PubMed ID: 32563850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
    McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL
    Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.
    Ullenhag GJ; Frödin JE; Jeddi-Tehrani M; Lidströmer N; Strigård K; Eriksson E; Samanci A; Choudhury A; Nilsson B; Rossmann ED; Mosolits S; Mellstedt H
    Clin Cancer Res; 2004 May; 10(10):3273-81. PubMed ID: 15161680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
    Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
    J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity.
    Shen KY; Liu HY; Li HJ; Wu CC; Liou GG; Chang YC; Leng CH; Liu SJ
    J Control Release; 2016 Jul; 233():57-63. PubMed ID: 27164542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.